googlefd16b42746daa692.html

September 2023 NCICT Newsletter

Dear all,

September was a busy month for NCIC with plenty of meetings and activities. A big thank you and shout out to the whole NCIC team who had successfully hosted the Taiwanese visitors, Dr Ting-Yu Yen (paediatric ID physician) and Shih-Han Chen (Research Nurse) from National University of Taiwan.

Fellow of IDSA

I am delighted to share that I have been named a Fellow by the Infectious Diseases Society of America (IDSA). The IDSA is an organisation of over 12,000 physicians, scientists, public health experts and other health care professionals dedicated to promoting health through excellence in infectious diseases research, education, prevention and patient care. I look forward to working and learning alongside them. For more information, visit www.idsociety.org.

NCIC Symposium and Workshop

Next month we will focus on the NCIC Symposium and Workshop. If you can, please join us for a full day symposium providing a comprehensive update on new pathways of care and novel interventions to deliver best practice care for treating and preventing infection in cancer. This symposium will be practical and interactive, with the opportunity to speak with experts in infectious diseases, health services research and implementation to help tailor interventions to your setting. More details and registration link available below.


“I wanted to extend my heartfelt thanks for the two-week training program you provided. It was an absolute honour to have the opportunity to visit Australia, explore Melbourne, train at Peter MacCallum, RMH, and meet the NCIC team.”

- Shih-Han Chen, Research Nurse National University of Taiwan


NCIC Symposium and Workshop

In person, Friday 6th October 2023
10am-4pm, Graduate House, UoM

Pathways to better infection care in cancer

Venue: Graduate house, University of Melbourne, Melbourne, Australia.  220 Leicester Street Carlton VIC 3053

Target audience: Medical, nursing, pharmacy practitioners involved in cancer care, including regional centres.

Ticket price: $150 for medical practitioners, $50 for nurses/pharmacist/allied health


Other upcoming events

VIDS Seminar

Monday 2nd October
12:30pm - 1:30pm AEST

“Update on CMV in the immunocompromised host”
Presented by Dr Michelle Yong

ANZMIG Mycology
Masterclass 2023

2nd to 4th November

NCIC Presenters:
Dr Abby Douglas, A/Prof Ben Teh and Dr Michelle Yong


Feature Paper

Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients.

Teh BW, Mikulska M, Averbuch D, de la Camara R, Hirsch HH, Akova M, Ostrosky-Zeichner L, Baddley JW, Tan BH, Mularoni A, Subramanian AK, La Hoz RM, Marinelli T, Boan P, Aguado JM, Grossi PA, Maertens J, Mueller NJ, Slavin MA.

The Lancet Infectious Diseases

“This is a consensus statement regarding the need to adequately capture information about infection in clinical trials and registries related to immunocompromised patients including cancer and transplant patients.  A/Prof Ben Teh led this work along with me and two colleagues from Europe: Prof Mikulska (Italy) and Prof Mueller (Switzerland) and it was endorsed and contributed to by 7 international societies including US and European groups focused on care of immunocompromised patients as well as our Australasian Society for Infectious Diseases.” - Prof Monica Slavin

“While there is still a lot to do to improve our reporting of infections, this work is an important start providing a tool to enable researchers to pool research data and ensure interstudy comparability. This will move research in this field forwards.” - A/Prof Ben Teh


Recent publications

Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients. Teh et al

Goals to score: The need for a minimum reporting dataset in studies of infection events in immunocompromised patients. Teh et al

Invasive aspergillosis in adult patients in Australia and New Zealand: 2017-2020. Tio et al

Recommendations on prevention of infections in patients with T-cell lymphomas: a narrative review and synthesis. Reynolds et al


Kind regards

Prof Monica Slavin, MBBS, MD, FRACP, FAAHMS
Head, Department Infectious Disease, Peter MacCallum Cancer Centre

Professor of Infection in Cancer and Transplantation, University of Melbourne Department of Infectious Diseases and the Sir Peter MacCallum Department of Oncology

Director, National Centre for Infections in Cancer and Transplantation

googlefd16b42746daa692.html